Virtuoso Therapeutics, Inc.
1 known investors
Virtuoso Therapeutics develops bispecific antibodies for cancer treatment, targeting limitations in existing therapies and novel molecular classes.
BiotechMedical Devices
1 known investors
Virtuoso Therapeutics develops bispecific antibodies for cancer treatment, targeting limitations in existing therapies and novel molecular classes.